IP Verse

Stada Arzneimittel patent opposition analysis

Get complete Patent Opposition Report for Stada Arzneimittel

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Stada Arzneimittel

Explore patent oppositions filed by Stada Arzneimittel against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2662094Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025
EP3781132Apixaban FormulationsBRISTOL MYERS SQUIBBDec 19, 2024
EP2395968Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 17, 2024
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 11, 2024
EP3744326Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICASep 5, 2024
EP3581183Tumor-Treating Pharmaceutical CompositionEISAI R&D MANAGEMENTAug 29, 2024
EP3782612Oral Formulations Of Cytidine Analogs And Methods Of Use ThereofCELGENEAug 8, 2024
EP3702351Formulation Comprising A Mek InhibitorARRAY BIOPHARMAAug 2, 2024
EP3270909Fixed Dose Combinations Comprising Etc1002 And One Or More Statins For Treating Or Reducing Cardiovascular RiskESPERION THERAPEUTICSJul 26, 2024
EP3263106Method For Suppressing Bitterness Of Quinoline DerivativeEISAI R&D MANAGEMENTJul 25, 2024

Latest patents of Stada Arzneimittel opposed by its competitors

Explore Stada Arzneimittel's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3324936Sep 28, 2022Method For Producing A Bortezomib Ester Solution6
EP3324937Aug 17, 2022Ready-To-Use Bortezomib Solution7
EP1591105May 27, 2020Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations6
EP2233127May 27, 2020Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations9

Top competitors of Stada Arzneimittel